| Trial Identifier: | D1683C00013 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT04445714 |
| Start Date: | April 2021 |
| Primary Completion Date: | December 2022 |
| Study Completion Date: | March 2023 |
| Condition: | Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version | |
| Bengali Translation | |
| Hindi Translation | |
| Kannada Translation | |
| Oriya Translation | |
| Punjabi Translation | |
| Tamil Translation | |
| Telugu Translation | |
| Urdu Translation |
| Country | Location |
|---|---|
| IN | Bangalore, IN, 560017 |
| IN | Bangalore, IN, 560076 |
| IN | Bhubaneswar, IN, 751007 |
| IN | Chandigarh, IN, 160012 |
| IN | Coimbatore, IN, 641018 |
| IN | Hyderabad, IN, 500024 |
| IN | Kolkata, IN, 700020 |
| IN | Lucknow, IN, 226003 |
| IN | New Delhi, IN, 110076 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company